Literature DB >> 16941649

Decline of striatal dopamine release in parkin-deficient mice shown by ex vivo autoradiography.

Shigeto Sato1, Tomoki Chiba, Shingo Nishiyama, Takeharu Kakiuchi, Hideo Tsukada, Taku Hatano, Takahiro Fukuda, Yasunobu Yasoshima, Nobuyuki Kai, Kazuto Kobayashi, Yoshikuni Mizuno, Keiji Tanaka, Nobutaka Hattori.   

Abstract

Parkin is the causal gene of autosomal recessive juvenile parkinsonism (AR-JP). Dopamine (DA) metabolism has been linked to Parkinson's disease (PD). To understand the pathogenesis of AR-JP, we generated parkin-deficient mice to assess the status of DA signaling pathway and examine DA release and DA receptor by ex vivo autoradiography. Ex vivo autoradiography using [11C]raclopride showed a clear decrease in endogenous DA release after methamphetamine challenge in parkin-deficient mice. Furthermore, parkin deficiency was associated with considerable upregulation of DA (D1 and D2) receptor binding in vivo in the striatum and increased DA levels in the midbrain. Our results suggest that dopaminergic neurons could behave abnormally before neuronal death. Copyright 2006 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16941649     DOI: 10.1002/jnr.21032

Source DB:  PubMed          Journal:  J Neurosci Res        ISSN: 0360-4012            Impact factor:   4.164


  16 in total

Review 1.  Genetically engineered mouse models of Parkinson's disease.

Authors:  Donna M Crabtree; Jianhua Zhang
Journal:  Brain Res Bull       Date:  2011-08-03       Impact factor: 4.077

Review 2.  Progress in the pathogenesis and genetics of Parkinson's disease.

Authors:  Yoshikuni Mizuno; Nobutaka Hattori; Shin-Ichiro Kubo; Shigeto Sato; Kenya Nishioka; Taku Hatano; Hiroyuki Tomiyama; Manabu Funayama; Yutaka Machida; Hideki Mochizuki
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2008-06-27       Impact factor: 6.237

3.  PARK2/Parkin-mediated mitochondrial clearance contributes to proteasome activation during slow-twitch muscle atrophy via NFE2L1 nuclear translocation.

Authors:  Norihiko Furuya; Shin-Ichi Ikeda; Shigeto Sato; Sanae Soma; Junji Ezaki; Juan Alejandro Oliva Trejo; Mitsue Takeda-Ezaki; Tsutomu Fujimura; Eri Arikawa-Hirasawa; Norihiro Tada; Masaaki Komatsu; Keiji Tanaka; Eiki Kominami; Nobutaka Hattori; Takashi Ueno
Journal:  Autophagy       Date:  2014-01-21       Impact factor: 16.016

Review 4.  Twenty years since the discovery of the parkin gene.

Authors:  Nobutaka Hattori; Yoshikuni Mizuno
Journal:  J Neural Transm (Vienna)       Date:  2017-06-15       Impact factor: 3.575

5.  Surprising behavioral and neurochemical enhancements in mice with combined mutations linked to Parkinson's disease.

Authors:  Meghan R Hennis; Marian A Marvin; Charles M Taylor; Matthew S Goldberg
Journal:  Neurobiol Dis       Date:  2013-09-26       Impact factor: 5.996

Review 6.  Transgenic animal models of neurodegeneration based on human genetic studies.

Authors:  Brandon K Harvey; Christopher T Richie; Barry J Hoffer; Mikko Airavaara
Journal:  J Neural Transm (Vienna)       Date:  2010-10-08       Impact factor: 3.575

7.  Identification and characterization of a novel endogenous murine parkin mutation.

Authors:  Chenere P Ramsey; Benoit I Giasson
Journal:  J Neurochem       Date:  2010-01-20       Impact factor: 5.372

Review 8.  An emerging role of PARK2 in cancer.

Authors:  Liang Xu; De-chen Lin; Dong Yin; H Phillip Koeffler
Journal:  J Mol Med (Berl)       Date:  2013-12-03       Impact factor: 4.599

9.  Enhanced Hyperthermia Induced by MDMA in Parkin Knockout Mice.

Authors:  Y Takamatsu; H Shiotsuki; S Kasai; S Sato; T Iwamura; N Hattori; K Ikeda
Journal:  Curr Neuropharmacol       Date:  2011-03       Impact factor: 7.363

10.  Mitochondrial dysfunction associated with increased oxidative stress and α-synuclein accumulation in PARK2 iPSC-derived neurons and postmortem brain tissue.

Authors:  Yoichi Imaizumi; Yohei Okada; Wado Akamatsu; Masato Koike; Naoko Kuzumaki; Hideki Hayakawa; Tomoko Nihira; Tetsuro Kobayashi; Manabu Ohyama; Shigeto Sato; Masashi Takanashi; Manabu Funayama; Akiyoshi Hirayama; Tomoyoshi Soga; Takako Hishiki; Makoto Suematsu; Takuya Yagi; Daisuke Ito; Arifumi Kosakai; Kozo Hayashi; Masanobu Shouji; Atsushi Nakanishi; Norihiro Suzuki; Yoshikuni Mizuno; Noboru Mizushima; Masayuki Amagai; Yasuo Uchiyama; Hideki Mochizuki; Nobutaka Hattori; Hideyuki Okano
Journal:  Mol Brain       Date:  2012-10-06       Impact factor: 4.041

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.